Archive for the ‘Health’ Category
In the secretive way that now seems to be standard practice for the UK government, the justice minister, Andrew Selous MP, revealed yesterday, in an answer to a written Parliamentary Question, that he is “currently trialling ‘Liaison and Diversion’ services”.
“These services place health professionals at police stations and courts to assess suspects for a range of health problems, including drug misuse, and make referrals to treatment and support. Information shared with the criminal justice system can be used to inform decisions, supporting diversion into treatment as part of an alternative to charge or to custody where appropriate.
We are also interested in problem-solving courts, such as drug courts, given evidence of success in other jurisdictions. Officials are now working with members of the judiciary to consider how the problem-solving approach might be developed for England and Wales.”
This is good news and is to be welcomed. However, why can’t the UK government engage with the electorate on drug law reform? Instead of dismissing all calls for reform out of hand, how about behaving as if the UK really is a democracy? Portugal has made massive improvements in public health through an enlightened and intelligent approach to drugs policy. Let us hope, one day soon the UK will catch up.
The subject of cannabis as medicine is certain to rise to the top of the UK news agenda in forthcoming weeks as a new Coronation Street storyline unfolds.
The character Izzy Armstrong (Cherylee Houston) who has Ehlers-Danlos Syndrome, will be seen suffering when her prescription medicine fails to alleviate her pain. Erica Holroyd (Claire King) will then suggest that she starts using cannabis as an alternative and ends up supplying Izzy with the drug. The programme will look at all aspects of the debate on medicinal cannabis and examine the legal implications and the far reaching consequences of Izzy’s actions for her family.
Now, three of the UK’s most important organisations in the field are joining forces to provide the media with facts, evidence and personal testimonies about medicinal cannabis.
CLEAR is the largest drugs policy reform group in the UK with nearly 600,000 followers. The British Medicinal Cannabis Campaign (BMCC) is an independent group consisting of 4,500 members, all of whom are UK-based medicinal cannabis users. UK CBD is the leading distributor of legal, cannabinoid nutraceuticals including the world famous Charlotte’s Web and Mary’s brands.
Roland Gyallay-Pap, managing director of CLEAR, commented:
“Not for the first time, but at a crucial time in the worldwide debate, the issue of medicinal cannabis will be addressed in a British soap. We have high hopes that this will stimulate the debate and bring the absurdity of the UK government’s position into sharp focus.”
Throughout Europe, the USA, Canada, Australia, Israel and South America, interest in and the use of medicinal cannabis is growing fast. The UK is now virtually isolated amongst first world countries with the stubborn refusal of government even to consider the evidence. However there is a growing clamour from politicians, scientists and doctors that it must address what is a deeply cruel and evidence-free policy. Hundreds of thousands already use medicinal cannabis and risk a criminal record just for trying to improve their health. In addition they have to deal with a criminal underworld and risk violence, contaminated and low quality product all because government refuses to take responsibility.
There is now an overwhelming body of peer-reviewed, scientific evidence on the safety and efficacy of cannabis as medicine. CLEAR published ‘Medicinal Cannabis: The Evidence’ in April 2015 which has received international acclaim and is now also available in a Spanish language edition. Download here in English or Spanish.
Individual briefings will be available on request to journalists, reporters, media organisations and other interested parties. Briefings will be led by Peter Reynolds, one of the nation’s leading experts on the science, medicine and politics of cannabis, Mark Scott, a representative of BMCC and Nicolas Ellis, founder and managing director of UK CBD.
Please contact CLEAR to arrange a briefing at your premises by appointment. Alternatively, a central London venue can be arranged on request.
Could This Be A Breakthrough In The UK Campaign For Medicinal Cannabis?
Cannabis used as medicine has appeared before in UK soaps but the news is that this Coronation Street storyline could be less jokey and trivial and actually deal in science and truth. If so it could be a major breakthrough against an intransigent government that flatly refuses even to consider the evidence.
Coronation Street is the world’s longest running soap opera still in production. Each episode reaches an average of between five and eight million viewers. It is deeply enmeshed in the fabric of British working class culture. If it puts a positive spin on medicinal cannabis it could change public opinion quicker than almost anything else.
Most senior politicians know the truth about medicinal cannabis but refuse to act, leaving millions in unnecessary pain and suffering for fear of a media backlash. But the media is changing too. Aside from a few individual dinosaur journalists and the bigots who edit the Daily Mail and Daily Telegraph, the rest of the media is pretty much onside.
The UK government’s position is nothing short of ridiculous, particularly given developments throughout the rest of the world. Look to Australia for the latest progressive, evidence-based change in policy, where very soon 23 million people will gain legal access to medicinal cannabis.
A positive Coronation Street storyline will give the cowards in the Department of Health and the refuseniks in the Home Office a way out. It is inevitable that reform will come. This could mean it is sooner rather than later.
I find it inconceivable that any sane human being can even consider expansion at Heathrow. The idea of increasing the traffic over what is already a hellhole, already unfit for human habitation, is madness.
The sickening amount of money pumped into the campaign to expand Heathrow raises very unusual feelings in me. It repels me and turns me against business. If this is the result of the profit motive then it is sickening, disgusting and demeans everyone involved.
I think those who advocate expanding Heathrow have slipped into a form of mental illness where common sense is overwhelmed by greed. But I think they’re wrong. It cannot be a wise decision on any basis. The cost is far, far too great.
I’m with Boris and a brand, spanking new mega airport in the Thames Estuary. It is an investment that will enrich our country, that will create so many jobs over so many decades that it can only be a winner. It is the only rational decision.
One of these vape pens contains Blue Dream sativa cannabis oil, 91% THC, the other is Hindu Kush indica cannabis oil, 85% THC and the spare cartridge has the dregs of some New York City Diesel sativa, 85% THC. You can’t tell which is which to look at them but each has a distinctive flavour and effect. They’re not completely odour free but almost.
This is the future of cannabis as a consumer product. It is cleaner, neater, handier, healthier and better for you than raw herbal cannabis. Most importantly, for medicinal applications, it homogenises all the compounds into an oil of consistent quality and content meaning that dosage and effect at last becomes predictable and reliable.
I have been investigating this theory for some time but my recent trip to Colorado enabled me to conduct some practical experiments and more thoroughly understand how this idea can work. I am now convinced that this is the way forward for the cannabis industry. Once we achieve legalisation in the UK, which is inevitable, probably in about five years, these pens are how cannabis will become available as a consumer product on the high street. They are also how medicinal cannabis will be dispensed. Your doctor’s prescription will be fulfilled by a cartridge with the appropriate blend of cannabinoids which you screw onto your battery and use immediately. Batteries will also be supplied on prescription, in the same way that syringes or blood glucose meters are for diabetics.
In Colorado dispensaries these pens are already available in a choice of strains and blends. Currently, the popular products contain 250 mg of THC in a blend of cannabis oil and propylene glycol (PG), just as e-cigs contain a nicotine oil and PG.
Alternatively, you can buy the oil of your choice and fill the cartridges yourself. This is undoubtedly the way to do it and a wide choice of oils is available, made by CO2 and solvent extraction processes. The Farm, my favourite dispensary in Boulder, is already supplying cannabinoid blends such as a 60% CBD, 12% THC, 4% CBN product which is clearly for medicinal use. I have no doubt that soon we will see a Charlotte’s Web product and Sativex-like blends with equal ratios of THC:CBD. Other, more sophisticated blends of other cannabinoids and probably terpenes will soon follow.
However, I am certain that some propylene glycol is a good thing. The oil vapes much better when diluted and PG is nothing to worry about, it is in many health, cosmetic and food products. It has many uses. It’s a solvent, humectant (keeps things moist), preservative and it helps absorption of some products. It is non-toxic.
There is further development work to be done. I believe there is a ‘sweet spot’ for the correct amount of PG, probably around 20%. I also think the battery and cartridges can be improved, particularly for medical use. Once this is achieved, a product like this with perhaps a 60:40 THC:CBD ratio should form the basis of an application to the Medicines and Health products Regulatory Agency (MHRA) for a marketing authorisation. It will knock Sativex into a cocked hat. In fact, if GW Pharma aren’t investigating this already then they are failing in their duty to shareholders. I shall certainly be doing all I can to research and facilitate the funding to bring such a product to market.
Yes, this is the future of cannabis. Imagine the packaging, marketing and merchandising opportunities for the recreational market. Understand the overwhelming benefits of this as medicine against the raw, herbal product. Yes, I know some will object and the tired old hippy luddites will say it’s a sell out and many more Big Pharma conspiracy theories will emerge but this is the future. Remember you heard it here first.
On Friday, 27th November 2015, the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London issued a press release titled “Study shows white matter damage caused by ‘skunk-like’ cannabis”. As a result, hundreds of media outlets across the world have published to the effect that cannabis use causes changes in the corpus callosum, the largest white matter structure in the brain, which is responsible for communication between the left and right hemispheres.
In fact, the study showed nothing of the sort. Even one of its authors, Dr Paola Dazzan, is on the record stating “It is possible that these people already have a different brain and they are more likely to use cannabis.”
Sadly, this is par for the course by King’s College and I can only assume is a corrupt attempt to sensationalise its work in order to drum up funding. Every time this institution publishes a study on cannabis it confuses causation and correlation.
For instance, Professor Sir Robin Murray’s annual study on cannabis and psychosis only ever shows correlation but when he talks to the press he always puts across the relationship between cannabis use and psychosis as causative.
We simply cannot rely on these so-called eminent scientists to be honest about their work. They are in the gutter and they aren’t looking at the stars, they are looking at their bank balances.
I have now written twice to Professor Shitij Kapur, Executive Dean of the IoPPN asking for an explanation but he hasn’t seen fit even to acknowledge my emails.
For anyone who takes an interest in the science of cannabis and the reasons this immensely valuable plant is banned, this example should give you an insight into the dishonesty, corruption and propaganda that is behind it all.
It’s the Institute of Psychiatry at Kings College London, yet again, with another terrifying story about cannabis that is immediately distorted, exaggerated and misrepresented by the scientifically illiterate hacks of Fleet Street.
This time though King’s College itself has reported the results of its own research inaccurately and published false and misleading claims.
Can King’s College explain why its press release is headlined “Study shows white matter damage caused by ‘skunk-like’ cannabis”, when the researcher Dr Dazzan says “It is possible that these people already have a different brain and they are more likely to use cannabis”? The truth is that the study does not show any causative effect. It is merely correlation yet here we have supposedly eminent scientists and scientific institutions reporting results falsely.
I have written to Professor Shitij Kapur, Executive Dean & Head of Faculty of the Institute asking for an explanation.
On a regular basis the team at King’s College publishes research about cannabis that suggests it is far more harmful than real world experience demonstrates. Always these studies contain the vital caveat that no causation can be shown for the various ‘differences’ or ‘changes’ that the researchers observe. Always, without fail, the researchers overlook this fundamental weakness in their work when they talk direct to the press. As a result we get ludicrous, inaccurate and wildly irresponsible reporting, particularly in the extremist rags such as the Daily Mail and Daily Telegraph but often extending, as today, even into The Times, supposedly a responsible and authoritative publication.
This latest study was led by Dr Silvia Rigucci of Sapienza University of Rome in conjunction with Dr Paola Dazzan and Dr Tiago Reis Marques from King’s College. Dr Razzan has fallen over herself in an undignified rush to gain media headlines. She is reported as saying: “There is an urgent need to educate health professionals, the public and policy makers about the risks involved with cannabis use.” Of course, in truth, all these people have been systematically misled about cannabis for many years. All that Dr Razaan is doing is contributing to the vast quantity of misinformation already out there by misrepresenting and overstating her own work.
This is a very small study with no proper controls that proves nothing either way about cannabis use. It is exaggerated and misrepresented by both King’s College and the scientists concerned, presumably in an effort to boost funding. This is the state of science on cannabis where vested interests promote misinformation which defies the real world experiences of hundreds of million of cannabis consumers worldwide. The team at King’s College displays all the classic markers of a cult. It pursues a belief in cannabis as the ‘devil’s lettuce’ as a quasi-religion. It dresses up its meaningless observational studies as significant evidence. It reinforces its belief by exaggerating and misrepresenting its work. It considers no alternative explanations and it endlessly repeats itself, its ‘studies’ and its presentation of them as proof of its own conclusions.
No one in their right mind can claim that cannabis is harmless but neither is there any evidence to support claims that it is dangerous. These untruths are promoted by vested interests such as researchers needing more funds, the alcohol industry guarding its monopoly of legal recreational drugs or newspapers seeking sensational stories.
It’s difficult to get hold of a copy of the actual study without paying for it. My advice is read the reports, understand the facts rather than the deliberate misinterpretations and expect more of the same. Remember that unless such evidence is compared with evidence in respect of other substances it is meaningless. All in all there is no evidence to suggest cannabis is any more harmful than coffee.